Table 1.
Characteristics | Studies (n) | % |
---|---|---|
Geographical location of study | ||
United States | 34 | 87 |
Europe (Spain, Finland) | 2 | 5 |
Asian (Taiwan, China) | 2 | 5 |
Australia | 1 | 3 |
Year of publication | ||
Before 2001 | 3 | 8 |
2005–2010 | 8 | 21 |
2011–2015 | 11 | 28 |
2016–2021 | 17 | 44 |
Application fielda | ||
Etiology | 0 | 0 |
Diagnosis | 26 | 67 |
Prognosis | 11 | 28 |
Therapy | 3 | 8 |
Clinical domain | ||
Oncology | 4 | 10 |
Cardiovascular | 6 | 15 |
Infectious diseases | 4 | 10 |
Pulmonary diseases | 7 | 18 |
Radiology | 3 | 8 |
Adherence to clinical guidelineb | 4 | 10 |
Maintenance of a problem list | 2 | 5 |
Other (eg, epilepsy, depression, hospital admission) | 9 | 23 |
Type of patient care | ||
Inpatient | 23 | 59 |
Outpatient | 7 | 18 |
Both | 6 | 15 |
Unknown | 3 | 8 |
Sample size validationc | ||
<500 | 20 | 51 |
500–10 000 | 13 | 33 |
>10 000 | 5 | 13 |
Free-text used for text mining | ||
Reports (eg, radiology reports, pathology reports) | 16 | 41 |
Orders (eg, clinical orders) | 2 | 5 |
Discharge summaries | 2 | 5 |
Clinical notes/free-text narratives (eg, free-text documents) | 14 | 36 |
Other (eg, messages, scheduling data) | 5 | 13 |
TM-CDS tool | ||
Software already developedd | 16 | 41 |
Developed for the studye | 23 | 59 |
Source available softwaref | 15 | 38 |
CDS: clinical decision dupport; USMSTF: United States Multi-Society Task Force; TM: text mining.
One study was included in 2 categories being, diagnosis and therapy.
This includes studies that tried to improve adherence to clinical guidelines.
This includes patients and free-text, Supplementary Appendix S2 shows which are patients and which are free-text.
This includes tools that were developed before the study, meaning already existing tools that were used in this study.
This includes tools that were developed in the study by the authors.
Tools whereof the source was available for others, containing tools that were developed for the study or tools whereof the software was already developed.